Discounted Cash Flow (DCF) Analysis Levered
Biomerica, Inc. (BMRA)
$0.9001
-0.02 (-2.18%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Revenue | 5.20 | 6.69 | 7.20 | 18.87 | 5.34 | 7.03 | 9.26 | 12.19 | 16.05 | 21.13 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -2.24 | -4.30 | -5.25 | -0.48 | -5.47 | -4.01 | -5.28 | -6.96 | -9.16 | -12.06 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.17 | -0.12 | -0.30 | -0.17 | -0.08 | -0.16 | -0.21 | -0.28 | -0.37 | -0.49 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -2.42 | -4.42 | -5.55 | -0.65 | -5.55 | -4.17 | -5.50 | -7.24 | -9.53 | -12.55 |
Weighted Average Cost Of Capital
| Share price | $ 0.9,001 |
|---|---|
| Beta | -0.618 |
| Diluted Shares Outstanding | 13.35 |
| Cost of Debt | |
| Tax Rate | -0.72 |
| After-tax Cost of Debt | 5.00% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 1.709 |
| Total Debt | 1.08 |
| Total Equity | 12.01 |
| Total Capital | 13.09 |
| Debt Weighting | 8.26 |
| Equity Weighting | 91.74 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Actual | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected | 2028 Projected |
| Revenue | 5.20 | 6.69 | 7.20 | 18.87 | 5.34 | 7.03 | 9.26 | 12.19 | 16.05 | 21.13 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.24 | -4.30 | -5.25 | -0.48 | -5.47 | -4.01 | -5.28 | -6.96 | -9.16 | -12.06 |
| Capital Expenditure | -0.17 | -0.12 | -0.30 | -0.17 | -0.08 | -0.16 | -0.21 | -0.28 | -0.37 | -0.49 |
| Free Cash Flow | -2.42 | -4.42 | -5.55 | -0.65 | -5.55 | -4.17 | -5.50 | -7.24 | -9.53 | -12.55 |
| WACC | ||||||||||
| PV LFCF | -4.09 | -5.29 | -6.82 | -8.81 | -11.38 | |||||
| SUM PV LFCF | -36.39 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 1.98 |
| Free cash flow (t + 1) | -12.80 |
| Terminal Value | 63,996.28 |
| Present Value of Terminal Value | 58,020.26 |
Intrinsic Value
| Enterprise Value | 57,983.87 |
|---|---|
| Net Debt | -8.64 |
| Equity Value | 57,992.51 |
| Shares Outstanding | 13.35 |
| Equity Value Per Share | 4,345.41 |